Lilly, Novo Nordisk back direct-to-employer programs to expand access to weight

(Reuters) -Eli Lilly said on Friday it plans to roll out an employer-focused obesity care model early next year, aiming to expand access to its blockbuster weight-loss drug through partnerships with third-party firms.

The program would give employers flexible cost-sharing options and integrate clinical support, Lilly said, bypassing traditional drug sales channels.

“Obesity care is the next frontier in employer health benefits,” said Ilya Yuffa, Lilly executive vice president.

“Companies that act now will lead the way, closing coverage gaps and building healthier, more resilient workforces.”

Separately, companies, including digital health firm Waltz Health and cardiometabolic care provider 9amHealth announced direct-to-employer programs in collaboration with Lilly and its Danish rival